Found 0 matching trials
Once-daily Oral Modified Release Hydrocortisone in Patients With Adrenal Insufficiency
PHASE2This is a randomised, controlled, open, two-armed, two-period cross-over, m...
Location
Multiple Locations
Safety and Efficacy Assessments of NeoKidney® in ESRD Patients Treated With Short Daily Hemodialysis
NAThe goal of this clinical investigation is to asses the safety and efficacy...
Bacillus Subtilis and Enterococcus Faecium Probiotic Plus Lipid-Lowering Therapy for Hypertriglyceridemic Acute Pancreatitis: A Prospective RCT
PHASE4Background: Hypertriglyceridemia-associated acute pancreatitis (HTG-AP) has...
Location
Department of Gastroenterology, Zhongshan Hospital, Xiamen University
Sitagliptin Mechanism of Action Study in Patients With Type 2 Diabetes Mellitus (0431-059)
PHASE1A clinical study to determine the safety, efficacy and the way sitagliptin ...
Location
Multiple Locations
Megestrol Acetate Plus LNG-IUS in Young Women With Early Endometrial Cancer
PHASE2To see if megestrol acetate plus Levonorgestrel-releasing intrauterine syst...
Location
Obstetrics and Gynecology Hospital, Fudan University
Berubicin in Adult Patients With Recurrent Glioblastoma Multiforme (WHO Grade IV)
PHASE1This is a multicenter, open-label, Phase 1b/2 efficacy and safety study of ...
Location
Uniwersyteckie Centrum Kliniczne Klinika Onkoligii i Radioterapii
Verbal and Written Instruction Versus Verbal and Written Plus Simulation in Patients With Breast Cancer and Their Caregivers
N/AThe purpose of this study is to compare two different ways of teaching peop...
Location
Memorial Sloan Kettering Cancer Center
A Combination Study of CAR-T Therapy in r/r B-NHL
PHASE2In registry studies of CAR-T products that have been marketed globally, pat...
Location
Ruijin Hospital, Shanghai Jiao Tong University School of Medicine
Efficacy of Cevimeline Versus Pilocarpine in the Secretion of Saliva
NAThe main objectives were: 1) To determine the efficacy of both cevimeline a...
Location
University of Kentucky Orofacial Pain Center College of Dentistry
Ublituximab Followed by Response-driven Addition of Umbralisib for Treatment-naive Follicular or Marginal Zone Lymphoma
PHASE2This is an open-label, Phase II interventional study in order to assess eff...
Location
University of Colorado Hospital